In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome

Seminars in Arthritis and Rheumatism

Volumn 47, Issue 2, 2017, Pages 216-221

  Ahn, Sung Soo ^a   Yoo, Byung Woo ^a   Jung, Seung Min ^a   Lee, Sang Won ^a   Park, Yong Beom ^a   Song, Jason Jungsik ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Ferritin; Macrophage activation syndrome; Systemic lupus erythematosus; Systemic onset juvenile idiopathic arthritis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; FERRITIN; FIBRINOGEN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL EVALUATION; CLINICAL FEATURE; FEMALE; FERRITIN BLOOD LEVEL; FEVER; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HUMAN; MACROPHAGE ACTIVATION SYNDROME; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; TREND STUDY; TRIACYLGLYCEROL BLOOD LEVEL; CLASSIFICATION; COMPLICATION; MIDDLE AGED; MORTALITY; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; FEVER; HOSPITAL MORTALITY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGE ACTIVATION SYNDROME; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 85014272190     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2017.02.002     Document Type: Article

References (23)

1. Tsokos, G.C., Systemic lupus erythematosus. N Engl J Med 365 (2011), 2110–2121.
2. Mak, A., Cheung, M.W., Chiew, H.J., Liu, Y., Ho, R.C., Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum 41 (2012), 830–839.
3. Fors Nieves, C.E., Izmirly, P.M., Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep, 18, 2016, 21.
4. Ravelli, A., Davi, S., Minoia, F., Martini, A., Cron, R.Q., Macrophage activation syndrome. Hematol Oncol Clin North Am 29 (2015), 927–941.
5. Weaver, L.K., Behrens, E.M., Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Curr Opin Rheumatol 26 (2014), 562–569.
6. Ravelli, A., Minoia, F., Davi, S., Horne, A., Bovis, F., Pistorio, A., et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 75 (2016), 481–489.
7. Ravelli, A., Minoia, F., Davi, S., Horne, A., Bovis, F., Pistorio, A., et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol 68 (2016), 566–576.
8. Henter, J.I., Horne, A., Arico, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48 (2007), 124–131.
9. Hochberg, M.C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 40, 1997, 1725.
10. Gladman, D.D., Ibanez, D., Urowitz, M.B., Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29 (2002), 288–291.
11. Wong, K.F., Hui, P.K., Chan, J.K., Chan, Y.W., Ha, S.Y., The acute lupus hemophagocytic syndrome. Ann Intern Med 114 (1991), 387–390.
12. Parodi, A., Davi, S., Pringe, A.B., Pistorio, A., Ruperto, N., Magni-Manzoni, S., et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 60 (2009), 3388–3399.
13. Kim, J.M., Kwok, S.K., Ju, J.H., Kim, H.Y., Park, S.H., Reactive hemophagocytic syndrome in adult Korean patients with systemic lupus erythematosus: a case–control study and literature review. J Rheumatol 39 (2012), 86–93.
14. Kumakura, S., Murakawa, Y., Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol 66 (2014), 2297–2307.
15. Atteritano, M., David, A., Bagnato, G., Beninati, C., Frisina, A., Iaria, C., et al. Haemophagocytic syndrome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci 16 (2012), 1414–1424.
16. Stahl, N.I., Klippel, J.H., Decker, J.L., Fever in systemic lupus erythematosus. Am J Med 67 (1979), 935–940.
17. Weitzman, S., Approach to hemophagocytic syndromes. Hematology Am Soc Hematol Educ Program 2011 (2011), 178–183.
18. Ramos-Casals, M., Brito-Zeron, P., Lopez-Guillermo, A., Khamashta, M.A., Bosch, X., Adult haemophagocytic syndrome. Lancet 383 (2014), 1503–1516.
19. Lisnevskaia, L., Murphy, G., Isenberg, D., Systemic lupus erythematosus. Lancet 384 (2014), 1878–1888.
20. Petri, M., Disease activity assessment in SLE: do we have the right instruments?. Ann Rheum Dis 66:Suppl. 3 (2007), iii61–iii64.
21. Touma, Z., Gladman, D.D., Ibanez, D., Taghavi-Zadeh, S., Urowitz, M.B., Systemic lupus erythematosus disease activity index 2000 responder index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials. J Rheumatol 38 (2011), 2395–2399.
22. Touma, Z., Gladman, D.D., Su, J., Ibanez, D., Urowitz, M.B., SLEDAI-2K does not conceal worsening in a particular system when there is overall improvement. J Rheumatol 42 (2015), 1401–1405.
23. Isenberg, D.A., Allen, E., Farewell, V., D'Cruz, D., Alarcon, G.S., Aranow, C., et al. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis 70 (2011), 54–59.